Chattem Acquires Worldwide Rights to ACT
Chattem Inc. announces the closing of its previously announced agreement to acquire the rights to ACT, a branded over-the-counter (OTC) anti-cavity mouthwash/mouth rinse, in Western Europe with worldwide trademark rights from Johnson & Johnson for $4.1 million in cash plus certain assumed liabilities.